ARTICLE | Clinical News
CRS-207: Phase IIb data
May 23, 2016 7:00 AM UTC
Top-line data from the open-label, North American Phase IIb ECLIPSE trial in 303 patients with metastatic pancreatic cancer who failed >=2 prior therapies showed that CRS-207 plus GVAX Pancreas cance...